Concepedia

Michael K. Krapf

MK

6

Publications

280

Citations

6

H-Index

2016

Active since

Affiliations

University of Bonn(Current)

Michael K. Krapf is an author at University of Bonn specializing in drug resistance, drug development, and medicine.

Top concepts

MedicinePharmacologyDrug DiscoveryDrug ResistanceDrug DevelopmentBiochemistryMedicinal ChemistryPharmacotherapyNatural SciencesChemical Biology

Publications per year

2016–2018

6

Publications

6

Synthesis and Biological Evaluation of 4-Anilino-quinazolines and -quinolines as Inhibitors of Breast Cancer Resistance Protein (ABCG2)

Michael K. Krapf, Michael Wiese · Journal of Medicinal Chemistry · 2016 · 53 citations · Full text

Inhibitory Activity, Medicinal Chemistry, Biochemistry +14

Synthesis and biological investigation of 2,4-substituted quinazolines as highly potent inhibitors of breast cancer resistance protein (ABCG2)

Michael K. Krapf, Jennifer Gallus, Michael Wiese · European Journal of Medicinal Chemistry · 2017 · 50 citations · Full text

Biochemistry, Medicine, Rational Drug Design +8

4-Anilino-2-pyridylquinazolines and -pyrimidines as Highly Potent and Nontoxic Inhibitors of Breast Cancer Resistance Protein (ABCG2)

Michael K. Krapf, Jennifer Gallus, Michael Wiese · Journal of Medicinal Chemistry · 2017 · 49 citations · Full text

Nontoxic Inhibitors, Medicinal Chemistry, Biochemistry +12

New Inhibitors of Breast Cancer Resistance Protein (ABCG2) Containing a 2,4-Disubstituted Pyridopyrimidine Scaffold

Michael K. Krapf, Jennifer Gallus, Sahel Vahdati et al. · Journal of Medicinal Chemistry · 2018 · 44 citations · Full text

Atpase Activity, Medicinal Chemistry, 2,4-Disubstituted Pyridopyrimidine Scaffold +15

2,4,6-Substituted Quinazolines with Extraordinary Inhibitory Potency toward ABCG2

Michael K. Krapf, Jennifer Gallus, Vigneshwaran Namasivayam et al. · Journal of Medicinal Chemistry · 2018 · 43 citations · Full text

Drug Target, Bioorganic Chemistry, Substrate Hoechst 33342 +16

Rows per page

1–5 of 6